Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
复制标题
通过 AAV8-Spc5-12 构建体过度表达 Klf15 对脊髓性肌萎缩症小鼠没有益处
DOI:
10.1101/717785
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Ahlskog N
中科院分区:
文献类型:
--
作者:
Ahlskog N
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by loss of thesurvival motor neuron(SMN) gene. While there are currently two approved gene-based therapies for SMA, availability, high cost, and differences in patient response indicate that alternative treatment options are needed. Optimal therapeutic strategies will likely be a combination of SMN-dependent and -independent treatments aimed at alleviating symptoms in the central nervous system and peripheral muscles. Krüppel-like factor 15 (KLF15) is a transcription factor that regulates key metabolic and ergogenic pathways in muscle. We have recently reported significant downregulation ofKlf15in muscle of presymptomatic SMA mice. Importantly, perinatal upregulation ofKlf15via transgenic and pharmacological methods resulted in improved disease phenotypes in SMA mice, including weight and survival. In the current study, we designed an adeno-associated virus serotype 8 (AAV8) vector to overexpress a codon-optimizedKlf15cDNA under the muscle-specific Spc5-12 promoter (AAV8-Klf15). Administration of AAV8-Klf15to severe TaiwaneseSmn−/−;SMN2or intermediateSmn2B/−SMA mice significantly increasedKlf15expression in muscle. We also observed significant activity of the AAV8-Klf15vector in liver and heart. AAV8-mediatedKlf15overexpression moderately improved survival in theSmn2B/−model but not in the Taiwanese mice. An inability to specifically induce Klf15 expression at physiological levels in a time- and tissue-dependent manner may have contributed to this limited efficacy. Thus, our work demonstrates that an AAV8-Spc5-12 vector induces high gene expression as early as P2 in several tissues including muscle, heart, and liver, but highlights the challenges of achieving meaningful vector-mediated transgene expression of Klf15.
登录
查看更多内容
影响因子:
7.7
作者:
Takashima M;Ogawa W;Hayashi K;Inoue H;Kinoshita S;Okamoto Y;Sakaue H;Wataoka Y;Emi A;Senga Y;Matsuki Y;Watanabe E;Hiramatsu R;Kasuga M
通讯作者:
Kasuga M
影响因子:
4
作者:
Boyer JG;Ferrier A;Kothary R
通讯作者:
Kothary R
影响因子:
29
作者:
Jeyaraj D;Scheer FA;Ripperger JA;Haldar SM;Lu Y;Prosdocimo DA;Eapen SJ;Eapen BL;Cui Y;Mahabeleshwar GH;Lee HG;Smith MA;Casadesus G;Mintz EM;Sun H;Wang Y;Ramsey KM;Bass J;Shea SA;Albrecht U;Jain MK
通讯作者:
Jain MK
影响因子:
46.9
作者:
Li, XY;Eastman, EM;Draghia-Akli, R
通讯作者:
Draghia-Akli, R
影响因子:
1.2
作者:
Lampe, Sara E. Gombash;Kaspar, Brian K.;Foust, Kevin D.
通讯作者:
Foust, Kevin D.